Bonesupport Holding

Regulatory Filings • Apr 20, 2021

BONESUPPORT AWARDED SYNTHETIC IMPLANTABLE PRODUCTS AGREEMENT WITH PREMIER

----- This press release has been modified to comply with the Premier IR guidelines -----

Lund, Sweden, 13.00 CET, 20 April 2021 – BONESUPPORT™, an emerging leader in orthobiologics for the management of bone injuries, has been awarded a group purchasing agreement for Synthetic Implantable Products with Premier. Effective July 1st, the new agreement allows Premier members, at their discretion, to take advantage of pricing and terms pre-negotiated by Premier for CERAMENT® BONE VOID FILLER.

"The awarded contract by Premier is a strong testimony and confirmation of the unique value CERAMENT offers hospitals, surgeons and patients. This agreement will further increase our potential reach across the US market", said Emil Billbäck, CEO of BONESUPPORT.

CERAMENT BONE VOID FILLER is an injectable, moldable and drillable synthetic bone graft substitute designed to help the bone heal in a natural way. CERAMENT resorbs at the same rate that bone forms and is ideal for both minimally invasive surgery and open procedures where bone remodelling is required.

Premier is a leading healthcare improvement company, uniting an alliance of more than 4,100 U.S. hospitals to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost.

CONTACT:

BONESUPPORT AB

Emil Billbäck, CEO +46 (0) 46 286 53 70

Håkan Johansson, CFO +46 (0) 46 286 53 70 ir@bonesupport.com

Cord Communications

Charlotte Stjerngren +46 (0) 708 76 87 87 charlotte.stjerngren@cordcom.se www.cordcom.se

About BONESUPPORT™

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient's own bone and have the capability of eluting drugs. BONESUPPORT's bone graft substitutes are based on the

patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver. The company is based in Lund, Sweden, and the net sales amounted to SEK 181 million in 2020. Please visit www.bonesupport.com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.